Clinical Trial Update: Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pegylated interferon for liver fibrosis in patients co-infected with HIV and hepatitis C; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections, Hepatitis C, Chronic | Phase 3 | Status: COMPLETED